Navigation Links
NanoBio(R) Corporation Completes $30 Million in Equity Funding by Meeting Key Development Milestones
Date:3/6/2008

ANN ARBOR, Mich., March 6 /PRNewswire/ -- NanoBio(R) Corporation has received its third $10 million tranche of equity funding from Perseus LLC, after having successfully met three critical development milestones: validating the efficacy and safety of its two topical treatments for skin infections and demonstrating the strength of its influenza vaccine in ferret studies.

The company, a spin-off from the University of Michigan, has received a total of $30 million over the past 18 months from Perseus LLC, a leading private equity management firm. The funding has enabled NanoBio to conduct phase 2 clinical trials on its two lead products, topical lotions NB-001 for herpes labialis (cold sores) and NB-002 for onychomycosis (nail fungus). Additionally, the funding has supported extensive animal studies supporting the company's nasal vaccines against influenza, hepatitis B and several additional pathogens.

Preliminary analyses of the data demonstrate the lotions have potent antiviral and antifungal effects without safety concerns or systemic absorption, according to NanoBio scientists.

Phase 2a and Phase 2b clinical trials on NB-001 are complete, while phase 2 clinical trials on NB-002 are in progress and will be completed by the first quarter of 2009. Final data will be presented after the data have undergone peer review processes.

"We're delighted by the considerable progress NanoBio has achieved in all dimensions, most notably its efficacy and safety data in the clinical realm," said Norman C. Selby, senior managing director at Perseus. "We are also pleased that the company has built a sound business infrastructure and a robust research program in the vaccine arena.

"The company's platform technology is proving to be highly effective in combating a broad range of viruses, bacteria and fungi, and we're eagerly anticipating the next round of data on its vaccine studies," he added.

Based on the positive data, NanoBio will move immediately to plan phase 3 testing of NB-001, said James R. Baker Jr., M.D., founder and chairman of NanoBio Corporation.

About NanoBio

NanoBio Corporation is a privately held biopharmaceutical company focused on developing and commercializing anti-infective products and mucosal vaccines derived from its patented NanoStat(TM) technology platform. The company's lead product candidates are treatments for herpes labialis (cold sores), onychomycosis (nail fungus), MRSA and mucosal vaccines for influenza and hepatitis B. The company's headquarters and laboratory facilities are located in Ann Arbor, Mich.


'/>"/>
SOURCE NanoBio Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Harris Corporation Teams with Cancer Treatment Services International to Advance Oncology Treatment
2. CEL-SCI Corporation Reports First Quarter Financial Results
3. NanoBio Corporation Presents Preclinical and Interim Clinical Data on Topical Treatments for Herpes Labialis and Onychomycosis at AAD 2008
4. Genaera Corporation Presents Promising Preclinical Type 2 Diabetes Data for Trodusquemine (MSI-1436) at Keystone Symposia
5. Divine Corporations Personal Lubricants Shown to Block Cancer-causing Viruses in a Study by the National Cancer Institute
6. Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation
7. Genzyme Corporation Selects Diplomat Specialty Pharmacy for 2008 Renagel Medicare Part D Assistance Program
8. CEL-SCI Corporation Announces 2007 Financial Results
9. Berkery Noyes Represented The Thomson Corporation in the Sale of CenterWatch and New England Institutional Review Board to Jobson Medical Information
10. AmpliMed Corporation Announces Promising 1-year Survival Data from Phase I/II Study of Amplimexon(R) in Metastatic Malignant Melanoma
11. Immunosyn Corporation Releases SF-1019 Study Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2017)... Echenberg, founder of Echenberg Institute, is announcing a new safe and effective ... intercourse and other painful pelvic pain conditions such as pelvic floor dysfunction, ... ... ... -based start-up company, VuVatech LLC, fills a void in the women,s wellness ...
(Date:7/10/2017)... July 10, 2017  US medical equipment and supply ... according to Medical Equipment & Supplies: United ... Focus Reports. Continued increases in demand for medical services ... the population and supported by gains in disposable personal ... supplies. New product introductions will also drive sales as ...
(Date:7/10/2017)... 10, 2017  BDI Group subsidiary Pathway Purchasing ... services organization serving specialty pharmacies, home infusion companies ... four significant, value-added member programs designed to help ... reimbursement and improve access and affordability for patients ... Pathway has ...
Breaking Medicine Technology:
(Date:7/25/2017)... ... 2017 , ... “Now Hiring!” is a popular phrase at Home Delivery ... record-breaking sales for over 30 consecutive years and now plans to hire more than ... offers excitement and growth at HDIS, following the company’s acquisition by Fortune 1000 company ...
(Date:7/25/2017)... ... 25, 2017 , ... Creative Pharmacist and ... the Pharmacist eCare Plan to Computer-Rx pharmacies through the STRAND platform. ... to develop the Pharmacist eCare Plan, a shared document detailing a patient’s current ...
(Date:7/25/2017)... ... 25, 2017 , ... Dr. Donna Bergman, professor of education ... published an article in the medical science journal Physical Medicine and Rehabilitation titled ... and the research that helped produce it, were written and conducted in collaboration ...
(Date:7/25/2017)... ... July 25, 2017 , ... Facing medical needs with a newborn boy this ... of a new benefit for employees that is uncommon in American business: 12 weeks ... supports me and other employees as new parents. It keeps our family life more ...
(Date:7/24/2017)... ... July 24, 2017 , ... Engineers at the University ... it produces the same kind of electrical energy that the body uses. , ... moving electrons. This flow of electrons out of the battery is generated by moving ...
Breaking Medicine News(10 mins):